Net profit of Ranbaxy Laboratories declined 91.52% to Rs 70.15 crore in the quarter ended March 2013 as against Rs 827.23 crore during the previous quarter ended March 2012. Sales declined 26.65% to Rs 1327.88 crore in the quarter ended March 2013 as against Rs 1810.23 crore during the previous quarter ended March 2012.
ParticularsQuarter EndedMar. 2013Mar. 2012% Var.Sales1327.881810.23 -27 OPM %2.4027.21 -91 PBDT33.60529.38 -94 PBT-11.69482.51 PL NP70.15827.23 -92
Powered by Capital Market - Live News
